ANI Pharmaceuticals ANIP Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's current ratio?
- ANI Pharmaceuticals (ANIP) reported current ratio of 3.1× in Q1 2026.
- How has ANI Pharmaceuticals's current ratio changed year-over-year?
- ANI Pharmaceuticals's current ratio increased by 17.4% year-over-year, from 2.7× to 3.1×.
- What is the long-term trend for ANI Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's current ratio has grown at a 4.5% compound annual growth rate (CAGR), from 2.2× to 2.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.